2014 Rules Revisions, Wyoming Controlled

Substances Act
  
 

By Allyson Dolence, PharmD Candidate, University of Wyoming

School of Pharmacy

Several housekeeping adjustments were made throughout the

act, including spelling, numbering, and formatting corrections, as

well as the deletion of outdated definitions and wording in Chapter

1. Chapter 2, Hearings, was updated to outline the procedures for

complaints and hearings. Changes to Chapter 3, Fees for Registration

and Re-registration, were minimal. Chapter 4 was not revised.

Chapter 5, formerly Rules of Practice and Procedure, has been

repealed because the process for contested case hearings is now

listed in Chapter 2.

Several important changes have been made to Chapter 6, Issuing,

Filing, and Filling of Prescriptions. The identification of patients

has been moved from Chapter 2 to Section 7. Section 10 clarifies

what a pharmacist can change on a Schedule II prescription. After

approval from the prescribing practitioner, the pharmacist is permitted

to change the drug strength, drug quantity, directions for use,

and dosage form. The pharmacist is permitted to add or change

the patient’s address with proper verification without consulting

the prescribing practitioner. The prescribing practitioner’s Drug

Enforcement Administration (DEA) registration number may be

added to a prescription drug order after consulting the prescribing

practitioner or verifying the number from another reliable source.

Required information may appear on the front or back of the prescription

drug order, and computer-generated data satisfies these

requirements. Any change made by the pharmacist shall be documented

and shall include the date, the name of person consulted,

and the initials of the pharmacist. A pharmacist is not permitted to

change the patient’s name, CS prescribed (except for generic substitution

permitted by state law), the date issued, or the prescriber’s

signature. Section 11 lists the process for multiple prescriptions

for a 90-day supply of Schedule II CS. An individual practitioner

may issue multiple prescriptions authorizing the patient to receive

a total of up to a 90-day supply of a Schedule II CS provided the

following conditions are met: each separate prescription is issued

for a legitimate medical purpose by a practitioner acting in the usual

course of professional practice; each individual prescription is dated

with the date it was prescribed and contains all other information

required by Chapter 6; the practitioner provides written instructions

on each prescription indicating the earliest date on which a

pharmacy may fill each prescription; and the practitioner concludes

that providing the patient with multiple prescriptions in this manner

does not create an undue risk of diversion or abuse.

Notable changes were also made to Chapter 8, Prescription Drug

Monitoring Program. These include updates to the process for

registering and using the online program (WORxPDMP.com). All

faxed (paper) requests must include the DEA registration number

for the pharmacy or practitioner. Pharmacists and practitioners

may request patient profiles electronically provided the following

conditions are met: the pharmacist or practitioner must first register

for access to the online system using the online registration; the

Board staff will activate the online access; and the Board staff shall

discontinue access to any pharmacist or practitioner whose license,

DEA registration, or Wyoming Controlled Substance Registration

has lapsed, been revoked, or suspended.

Chapter 4, Records and Inventories, was not revised, as it was

updated in 2011, and no further revisions are needed at this time.

Chapter 7, Administrative Inspections, was reviewed by the Board

and no revisions were made.quoted from here